HOME >> BIOLOGY >> NEWS
St. Jude develops vaccine against potential pandemic influenza virus H5N1 using reverse genetics

ce of viruses."

Webster is the director of the WHO's U.S. Collaborating Center at St. Jude that studies animal influenza viruses. It is the only WHO laboratory that focuses on the transmission of animal viruses to humans.

Webster's laboratory has sent the seed H5N1 vaccine to the Centers for Disease Control in Atlanta and the World Influenza Center in London for further testing, in preparation for initial Phase I and Phase II trials in humans. "It's important to move right along with these trials in case the virus begins spreading from person to person," Webster says. Led by Richard Webby, Ph.D., and Daniel Perez, Ph.D., the St. Jude laboratory team successfully modified a technique called reverse genetics to permit them to develop the H5N1 vaccine so quickly. Using the samples of H5N1 obtained from Hong Kong, Webby mixed two genes from H5N1 with six genes from a second virus (A/PR8/34)[H1N1]). H1N1 is a rapidly growing "master" strain of virus commonly used to make vaccines.

The genes from flu viruses produce proteins called HA and NA, which are on the surface of the virus, in full "view" of the immune system. Webby took the modified gene for HA and the NA from H5N1 and mixed them inside a cell with six genes from H1N1. The HA gene was modified to abolish its ability to cause disease and therefore made it safer to use in the vaccine.

The genes mixed together, and the resulting vaccine virus produced in the cell thus carried HA and NA from H5N1. But because of the alterations to the HA, and the rest of the genes being derived from H1N1, the new virus vaccine cannot cause disease. Rather, it can only stimulate the immune system to respond to H5N1.

"The St. Jude vaccine is like a gun without ammunition," said Elaine Tuomanen, M.D., director of the St. Jude Department of Infectious Diseases. "The vaccine looks deadly enough for its HA and NA proteins to alert the immune system. But in reality, it's carrying blanks that can't cause dis
'"/>

Contact: Bonnie Cameron
bonnie.cameron@stjude.org
901-495-4815
St. Jude Children's Research Hospital
2-Apr-2003


Page: 1 2 3

Related biology news :

1. Carnegie Mellon neuroscientist develops tool to image brain function at the cellular level
2. Carnegie Mellon U. develops microgel to recover enzymes for manufacturing, research assays
3. Scientists findings may lead to better understanding of how that sleep develops, matures
4. Fox Chase Cancer Center researcher develops new model for studying prions mad cow disease
5. US develops lethal new viruses
6. Brookhaven Lab develops ThraxVac to clean up anthrax
7. Carnegie Mellon develops new process for growing bone
8. Cancer could be caught before it develops
9. University of Ulster develops DNA fingerprint techniques to fight bio-terrorism
10. Clothing from Corn: DuPont develops innovative process to create polymer from renewable resources
11. Rice develops nanosensor for precision chemical analysis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/14/2019)... ... ... Highmark Health’s VITAL Innovation Platform has been named the winner in the ... of the top honors in the awards. Winners were announced at an event on ... event on May 10 that also raises funds for Carnegie Science Center programs that ...
(Date:3/11/2019)... ORLANDO, Fla. (PRWEB) , ... March 11, 2019 , ... ... parenting among U.S. LGBTQ Millennials compared to previous generations; 77% of those aged 18 ... 54 age group and 33% of those aged 55 and older.(1) Among all LGBTQ ...
(Date:3/9/2019)... ... March 07, 2019 , ... StressMarq Biosciences Inc., a ... today announced the publication of its recent PCT patent application describing ... a pre-clinical stage of development, moves the company into the drug discovery field. ...
Breaking Biology News(10 mins):
(Date:3/15/2019)... (PRWEB) , ... March 15, ... ... of 100% equity in American Process Inc. and affiliate companies including AVAPCO ... Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D center in Thomaston, ...
(Date:3/14/2019)... ... March 14, 2019 , ... Open registration ... “Navigating the Full Spectrum of Case Management,” continues as CMSA makes plans to ... is the only case management industry conference serving the educational and networking needs ...
(Date:3/14/2019)... ... March 13, 2019 , ... ... 2019 ISPE Europe Biotechnology Conference , taking place in Brussels, Belgium on 25–26 ... practices, technical and operational solutions, and innovative approaches. , “Biopharmaceuticals have become ...
(Date:3/12/2019)... ... March 12, 2019 , ... Diagenode, ... has launched its third generation long-fragment DNA shearing innovation, the Megaruptor 3. This ... user-friendly interface, automated processing, and the ability to process up to 8 ...
Breaking Biology Technology:
Cached News: